We have examined the ability of recombinant adenoviral vectors to transduce human hematopoietic cells. Our findings indicate that adenovirus readily infects a large proportion of CD34+ cells. Using adenovirus vectors that transduce either a lac2 or an alkaline phosphatase reporter gene, we observed up to 45% of total CD34' cells infected. Upon more detailed analysis, we observed comparable levels of transduction for CD34+/CD38-cells and for CD34+ cells in Go phase of the cell cycle. Importantly, exposure to adenovirus resulted in negligible levels of toxicity as assayed by propidium iodide staining and colony-forming ability. Using adenovirus vectors, we also describe a model system for regulated gene expression in early hematopoietic tissues. CD34+ cells ENE TRANSFER into primitive hematopoietic cells has been a very active area of research for many years."3 Numerous strategies have been evaluated for both basic research and clinical application^.^.^ To date, the most prevalent vehicle for stem cell gene transfer has been the retroviral vector. Studies in animal systems have shown that retrovirally marked stem cells can contribute to all major hematopoietic lineages and that a small number of pluripotent clones can effectively repopulate an entire hematopoietic system for extended periods of time.8-" Furthermore, infection of stem cells with therapeutically relevant genes has been modeled for a variety of applications.'*"' These studies have achieved levels of gene transfer that suggest that stem cell transduction may have clinical utility. Human gene transfer trials have shown that it is possible to achieve significant levels of retrovirally marked hematopoietic tiscal difficulty of transducing primitive human stem The most likely impediment to efficient gene transfer may be the quiescent nature of stem cells. Moreover, in addition to their predominantly noncycling status, primitive cells have proven difficult to manipulate in culture. Typically, conditions that stimulate growth of stedprogenitor cells also incur a rapid loss of developmental potential. Thus, although recent results appear more encouraging, it is perhaps not surprising that traditional techniques for retroviral gene transfer have often been less than optimal when applied to human stem cell gene transfer.
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To investigate alternative strategies for the transduction of human stem cells, we have examined the use of adenoviral vectors. One previous study has suggested that human bone marrow (BM) may be permissive to adenovirus infection; however, primitive cell types were not specifically examined." Although standard recombinant adenovirus does not usually allow stable integration, it has been extremely successful for transient gene expression in many systems. Furthermore, adenoviral vectors frequently express transgenes at high levels (not subject to integration site-specific effects), have a broad host range, and have been shown to infect nondividing cells.22~2' Clearly, this approach is not currently suited for correction of genetic deficiencies or other situa- tions in which stable gene transfer is required. However, for situations in which transient expression is sufficient, adenovirus has the potential to be an effective gene transfer vehicle.
We have found that adenoviral vectors readily infect primitive human hematopoietic tissue. High levels of expression can be detected in up to 45% of total CD34+ cells. In addition, expression can be seen at similar levels in CD34+/ CD38-cells as well as CD34+ cells in Go. Consequently, we propose that adenoviral vector transduction is a useful means of transferring and expressing genes in primitive human hematopoietic cells.
placental-like alkaline phosphatase (mAP) transgene. To create Ad-MFG-AP. the MFG-s-mAP expression cassette was inserted between the P~a t I1 and C/o 1 sites of the pAdlox vector and recombined with Q5 viral DNA in CRE8 cells (S.F. Hardy, manuscript in preparation). The mAP transgene was constructed from the reporter plasmid pSEAP (Clonetech, Palo Alto. CA) and a genomic subclone designated pSV2APAP (containing the membrane-anchoring domain). For generation of the S' segment of mAP containing a compatible NCO I site for insertion in the MFG-s retroviral vector, oligonucleotide primer pairs S'-CCACATGTTGCTGCTGCTGCTGCTGCT-GGCC-3' (forward) and S'-CCACATATGGCAAGCGGT-3' (reverse) were used to amplify a 270-bp fragment from the pSEAP template. The fragment containing the internal coding region of mAP was obtained by digestion of pSEAP with Nde I and BssHII. Finally, a 200-bp fragment containing the 3' membrane-bound AP segment was obtained by polymerase chain reaction (PCR) amplification of pSV2APAP using primers S'-TTCGCGCGCGGCCCGCA-3' (forward) and S'-CGGGATCCTTATCAGGGAGCAGTGGC-3' (reverse). The three fragments were ligated together and cloned into the MFG-s vector. The construction of Ad-tet-ogal and Ad-tTA from pUHC-13-3 and pUHD IS-l are described elsewhere (S.F. Hardy and J. Forsayeth, manuscript in preparation).' Ad-MCLacZ was a generous gift from lnder Verma (Salk Institute)."
All viruses were plaque-purified and expanded on 293 cells using the standard technique. Each viral inoculum was purified by a CsCl step gradient followed by a CsCl equilibrium gradient. The final viral band was diluted I:l with sterile glycerol and stored at -20°C. Concentrations of the viruses were determined by measuring their optical density at 260 nm and converting this figure to particles per milliliter, assuming that 1 X 10'' particleslmL equals (Table 2) . cells were stained for CD34 and AP (propidium iodide was also included to distinguish dead cells), and 100 cellslwell were deposited directly into 24-well plates containing 0.5 mL methocult (Stem Cell Technologies, Vancouver, British Columbia, Canada). Sort gates were set using appropriate isotype controls. To identify CD34' cells in G,, (Fig 4) , a novel technique was used that combines staining for cell surface antigens, nuclear antigens. and DNA simultaneously (Jordan et al. manuscript in preparation). Briefly. cells were stained for cell surface antigens (CD34 and CD38) using standard procedures. Next, samples were fixed in 0.4% formaldehyde (Polysciences. Wamngton. PA; Ultrapure grade) for 30 minutes on ice, followed by permeabilization with 0.1 %Triton For personal use only. on November 11, 2017. by guest www.bloodjournal.org From X-l00 for 30 minutes on ice. Cells were then stained with the MIBand samples were incubated at 4°C overnight. Samples were then 1 antibody (anti-Ki-67-FITC; Immunotech) and finally stained with centrifuged at full speed for 30 minutes in a Beckman microfuge 0.5 pglmL 7-aminoactinomycin D (7-AAD) overnight. For charac-(Beckman, Palo Alto, CA). Supernatant was extracted twice with terization of primitive tissue in Go, cells were identified that were phenolkhloroform and DNA was precipitated with isopropanol. Fipositive for CD34, yet failed to stain for nuclear antigen Ki-67.
nally, samples were resuspended in TE (10 mmol/L Tris, 1 mmol/ Previous studies have shown that lack of expression of Ki-67. com-L EDTA) + 20 p g h L RNase A. Before Southern analysis, 10% of bined with staining for DNA content, can be used to identify cells each sample was subjected to 10 rounds of PCR using primers in Go.2y.2" All analyses and sorting were performed on a FACStar specific to the lacZ gene that yield a product of 692 bp (5"CGATITPlus flow cytometer (Becton Dickinson) equipped with 488 nm argon CCATGTTGCCACTC-3' and 5'-TCACACTCGGGTGAlTACCAand 633 nm HeNe lasers. Viability was determined by standard 3'). This step was performed to amplify the samples such that they propidium iodide staining.
could be more easily detected by Southern blot. One-tenth of each 
23.24
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From brane-anchoring domain so that the gene product is maintained on the cell surface. Consequently, we can detect expression of this gene in live cells via standard flow cytometric analysis (see the Materials and Methods). Target cells for infection were derived from normal adult BM and were enriched for CD34+ cells (60% to 80% purity) using an immuno-affinity column. As shown in Fig 1, AP' cells are readily evident when BM CD34' cells were infected. In addition to uninfected cells, as a further negative control, cells infected with Ad-MCLacZ were analyzed for nonspecific AP staining. This sample was negative, showing that the observed staining is not due to exposure of CD34+ cells to adenoviral particles. Further analysis of CD34+ cells from both MPB and umbilical cord blood (CB) showed that these alternative sources of primitive tissue are also permissive for adenovirus infection (Fig 2) . Titration experiments show that transduction usually saturates in the range of 25% to 35% of the CD34+ population at an MO1 of approximately 500 (Fig 3, top panel) . When the time of exposure to adenovirus was analyzed, it was found that approximately 50% of transduction (for a constant MOI) occurs during the first 2 hours of infection. The remaining 50% appeared to occur at a roughly constant rate over the subsequent 24 hours (Fig  3, bottom panel) .
Infected cells were further characterized by examining additional surface markers and cell cycle status. We observed comparable levels of transduction between CD34+ cells and the more primitive CD34'/CD38-subpopulation (Fig 4A) . In addition, using a novel technique that allows delineation of CD34' cells in Go, G , , or G2/S/M phases of the cell cycle (see the Materials and Methods), we observed that reporter gene expression was readily evident for CD34' cells in G,, (Fig 4B) .
When total mononuclear BM cells were examined for adenovirus infection, we found that, aside from cells of a CD34' phenotype, only the erythroid lineage (glycophorin A-positive cells) showed appreciable levels of transduction (approximately 10% at an MO1 of 100). T and B lymphocytes were almost entirely negative for expression of the reporter gene (1% to 2% positive T cells and 0% to 0.5% positive B cells). Granulocytes were only weakly positive, with 2% to 4% of CD 15 cells being positive for AP staining. Monocytes (CD14+ cells) also showed very low levels of transgene expression (1% to 2%).
Functional ability of adenovirus infected CD34' cells. For the titration experiment shown in Fig 3, we also assayed both viability and functional ability of cells exposed to adenovirus. Propidium iodide staining of infected cells showed only a very slight degree of toxicity as a consequence of adenovirus infection (Table 1 ). The colony-forming ability of CD34' cells after adenovirus infection was assayed by plating cells in methylcellulose. Table 2 shows the results of three experiments in which CFU-C were scored for virus infection ranging from an MO1 of 1 to 500. Note that for experiments 1 and 3, no statistically significant reduction in myeloid or erythroid colonies is seen, even at the highest MO1 tested. Experiment 2 did show a reduction in myeloid colonies of approximately 30% at an MO1 of 500 and some loss of burst-forming units-erythroid (BFU-E) at all virus concentrations. Finally, to directly show that adenoviral vectors were transducing functional progenitors, we sorted infected cells into CD34+/AP+ versus CD34'IAP-populations and assayed for CFU-C. Table 3 shows that CD34+/AP' cells clearly do have colony-forming ability, albeit at a somewhat lower frequency that the AP-cells.
Molecular analysis of adenoviral transduction. TO corroborate data obtained from the expression studies, we also analyzed for the presence of the viral genome in transduced cells. CD34' cells were infected with the Ad-MCLacZ virus and, at 2, 5 , and 8 days after infection, cells were harvested. For Southern analysis, DNA was isolated by Hirt extraction and subjected to a limited PCR amplification (10 cycles). In addition, part of each sample was also analyzed for expression of lacZ by FDG ~taining.'~ The presence of viral DNA was evident at all timepoints (Fig 5) , with an apparent dimi- At the time of flow cytometric analysis (48 hours after infection), each sample was stained with propidium iodide (PI) to determine viability. %PI' indicates the percentage of dead cells in each sample (data derived from the same samples as shown in Fig 3, top panel) .
Abbreviation: ND, not determined. to the total number of cells in the culture. Thus, as the population expanded over time, the absolute number of positive cells appeared to remain roughly constant.
CD34+/CD38-cells
Regdated gene expression using a coinfection strategy. In an effort to achieve an inducible gene expression system, we tested the use of a two-virus transduction strategy. One virus carried a lacZ reporter gene under the transcriptional control of a minimal CMV promoter and flanked by seven tet operator sites (Ad-tet-&l). The second virus vector carried a chimeric transcription factor gene composed of the tet repressor and the VPI 6 transactivator domain (Ad-tTA). Previous studies have shown that this hybrid transactivator molecule strongly activates expression of the tet-&l gene.'5 Figure 6 shows analysis of the coinfection experimental strategy. The Ad-tet-&l virus alone (sample 2) fails to express &gal. whereas cells coinfected with Ad-tet-&gal and the Ad-tTA virus (sample 3) show a strong induction of &gal expression. Moreover, as shown previously in other systems. the interaction between tet-Ogal and tTA is sensitive to the presence of tetracycline (samples 4 through 7) .25 Furthermore, this inhibition shows a dose-dependent response, At the time of flow cytometric analysis (48 hours after infection), part of each sample was plated in methylcellulose medium to determine progenitor frequency (1.000 cells/35-mm plate). Each data point is derived from triplicate samples. Data are derived from the same samples as those analyzed in Fig 3 (top panel) .
Abbreviation: ND, not determined.
with higher levels of tetracycline being sufficient to completely block lacZ expression.
DISCUSSION

Several studies have documented the presence of adenovirus in human lymphoid
Although reports vary considerably in their findings, it appears that some adenovirus serotypes can establish a latent or chronic infection in human lymphocytes. A more recent study has shown that adenovirus may replicate to some degree in human BM cell cultures.*' Thus, there are precedents for at least a low level of viral infectivity for human hematopoietic cells. The studies described in this report are the first to specifically document adenovirus transduction of primitive human hematopoietic cells. This finding may have gone previously undocumented for several reasons. First, only a limited number of hematopoietic cell types show significant permissivity to adenovirus infection. Our analysis of the major hematopoietic lineages showed only low levels of infection for all phenotypes except CD34' and glycophorin A'. Thus, studies using unfractionated BM might easily have failed to note transduction in the CD34' compartment. Second, the transcriptional control requirements of genes in primitive cells may differ substantially compared with other cell types. Consequently, earlier studies may have used promoter/enhancer combinations poorly suited for gene expression in early hematopoietic cells. Third, even for the more permissive cells described in this study (ie, CD34' and glyA'), the virus concentration necessary to see a large percentage of positive cells was relatively high. Finally, all data presented in our experiments Two days after infection with the Ad-MFG-AP virus, cells were stained and sorted into CD34'1AP' and CD34'1AP-populations. Both CFU-GM and BFU-E are expressed as number of colonies per 100 sorted CD34' cells. A total of 32 wells (100 cellslwell) were analyzed for each phenotype.
were generated using human tissue, whereas previous attempts may have used animal cells. We do not know the efficacy of adenoviral vectors for transduction of hematopoietic cells of any species other than human.
Within the CD34' population, there appeared to be a sub- we have not been able to determine the cause of this apparent tropism. None of the various surface antigens we have examined (see the Materials and Methods) correlates with adenoviral transduction. Infection greater than an MOT of 500 to 1,000 was not tested, because this appeared to be the threshold beyond which significant levels of toxicity were evident. It is possible that virus infection does not plateau at the levels shown (see Fig 3) ; however, due to toxicity, it becomes difficult to accurately measure higher levels of transduction. It has also been shown that the av integrins facilitate uptake of adenovirus for some cell type^.'",^' We examined the expression of av (CD51) by flow cytometric analysis and saw only very low levels of staining (2% to 3%) on CD34' cells (data not shown).
Regardless of the above issues, a large proportion of cells with a primitive phenotype clearly are permissive to transduction. Thus, it seems likely that adenovirus can be useful for expressing genes of interest in at least some human stem cells. It has previously been shown that adenovirus transduc-1153 tion of retrovirus receptors can increase retroviral infectivity in various cultured cell lines.3K Given our findings with primary hematopoietic tissue, this strategy should also be feasible for CD34' cells. In addition, for situations in which transient gene expression might be preferable to stable gene transfer, adenovirus could also be an effective vehicle. For example, several investigators have proposed using retroviral vectors to transduce the MDRl gene into stem cells to increase drug re~istance."'~~' It is possible that stable long-term expression of this gene may be detrimental and that highlevel transient expression (via adenovirus transduction) might suffice. Moreover, in the case of noncycling cells, adenovirus has been shown to be stably maintained for extended periods.'.' Thus, for quiescent stem cells, expression of transgenes might be effectively stable, despite the episomal nature of the adenovirus vector. A potential problem for in vivo application of this technology is the well-documented immune response to adenovirus infected cell^.'^"'" However, recent improvements in adenovirus vector design and production suggest that future developments may minimize this problem.'" Our data also show that tightly regulated gene expression can be achieved for primary hematopoietic cells. Using the tTA-dependent promoter/transactivator system and a twovirus coinfection strategy, we obtained gene expression that could easily be regulated by adding tetracycline to the culture medium. This approach might be particularly useful for studies of genes in which temporal regulation or dosage effects are of interest (eg, cell-cycle or developmental stage-specific genes).
A recent study by Clarke et aI4 has suggested that adenovirus could be useful clinically for purging of malignant cells from BM specimens. This strategy calls for the transduction of tumor cells with a gene predicted to cause apoptosis in neoplastic cells. Using the Bcl-x, gene, a functional inhibitor of Bcl-2, the investigators observed impressive tumor-specific cell death in the absence of any apparent marrow toxicity. In light of findings reported in this study, their data may indicate that expression of Bcl-xs in primary hematopoietic cells is benign. Alternatively, the Rous Sarcoma virus (RSV) promoter used to express Bcl-x, may not function well in stem and progenitor cells. Because our data suggest that hematopoietic cells are effectively transduced by adenovirus, we feel that, despite the success of Clarke et a1,4" strategies for purging cancer cells from marrow should be approached with caution.
In conclusion, we have shown that recombinant adenovirus vectors can transduce human CD34' cells. This was observed for human BM, MPB, and umbilical CB. Moreover, infection was evident at comparable levels in the more phenotypically primitive CD34'/CD38-subpopulation and in quiescent (G,) CD34' cells. Finally, it was possible to show tightly regulated expression of an adenovirus transgene using a two-virus coinfection strategy with the tet/VP16 inducible system. Therefore, we suggest that adenovirus may have broad applicability as a gene transfer vehicle for studies of primitive human hematopoietic cells.
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